CaloSense Health

CaloSense delivers better chronic obesity management—driven by data, powered by AI, and delivered by humans—through a fully managed care platform that supports long-term success for patients and providers alike. Our initial focus is the bariatric surgery space, where we help clinics improve outcomes and scale their operations by providing structured support before and after surgery. The CaloSense model combines a tailored treatment plan, a purpose-built Remote Patient Monitoring (RPM) system, and proactive, human-led care. The platform tracks patient data through connected devices and enables real-time, personalized intervention. In collaboration with clinical experts, we’ve developed a customizable follow-up protocol that guides patients through every stage of their journey. Designed for seamless integration into clinic workflows, the service is fully reimbursed by insurers and requires no additional overhead. CaloSense is currently operating across the U.S. and continues to expand, helping providers increase adherence, reduce dropout, and deliver lasting impact for patients living with severe obesity.

CaloSense Health has raised $2.06M in total funding across 8 rounds. The company is currently at the Pre-Seed stage. Key investors include Comda, Techstars Tel Aviv Accelerator, Techstars Accelerator.

CaloSense Health was founded in 2020 by Nitzan Shenar (Co-founder & CEO), Alon Ezra (Co-founder & CTO).

CaloSense Health operates in Health Tech & Life Sciences, Digital Healthcare, Patient Remote Monitoring, with core technologies in Platforms & Interfaces, Mobile, Artificial Intelligence, Machine Learning. Target customers: Healthcare & Life Sciences, Healthcare, Providers.

CaloSense Health is based in Beni Berman St 2, Netanya, Israel, Center District. The company also has offices abroad.